Company intelligence / Profile preview

Amico Laboratories Limited

Dhaka, Dhaka, Bangladeshamicolaboratories.lookchem.com ↗

Ownership: Private
Employees: ~350
Development stage: Commercial

Overview

Amico Laboratories is one of the fastest-growing pharmaceutical companies in Bangladesh. It manufactures and markets a wide range of human healthcare products with an emphasis on quality and efficacy. The company operates under GMP standards with modern production facilities in Dhaka. Its portfolio includes antibiotics, antimalarial drugs, anticancer agents, NSAIDs, CNS medications, cardiovascular treatments among others—supplied both domestically across Bangladesh and exported to Latin America and Africa.

Therapeutic areas: Men's HealthOncologyRheumatologyCardiovascularNeurologyInfectious Diseases
Modalities: Small molecules (tablets, capsules, injectables, ointments)Liquid orals and injectablesAntibiotics, antimalarials, anti-cancer drugs, NSAIDs, CNS drugs
Industry: Biotech

Beyond the preview

Go deeper on Amico Laboratories Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amico Laboratories Limited.

Explore the full profile